Nikolai Khaltaev GARD Meeting ERS Congress 3 September, Munich Mid Term Financial Report January – July 2006 Nikolai Khaltaev GARD Meeting ERS Congress 3 September, Munich

Overview GARD Contributions

Companies accepted by WHO as GARD Observers Altana Pharma Astra Zeneca Boehringer-Ingelheim Int. GmbH Chiesi Farmaceutici S.p.A. GlaxoSmithKline Merck & Co., Inc. Mitsubishi Pharma Corporation Novartis Pharma AG Pfizer Inc. Sanofi-Aventis Schering Plough Corporation Stallergens SA UCB Farchim SA

Overview GARD Expenses

Detailed GARD Expenses obligated from GARD Participants

Detailed GARD Expenses obligated from GARD Observers

Remaining Balance Total Allotted Contributions 465,651 Total Obligated and Earmarked Expenses 419,016 Remaining Balance 46,635